Health Technology Assessment (HTA) helps figure out if new medical tools and treatments are useful, safe, and worth the money ...

Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care. The life cycle of a drug encompasses phases of market exclusivity, ...

Today, the Center for Innovation & Value Research (the Center) released a new report highlighting actions for stakeholders to ensure health disparities and equity are being addressed in health ...

The rapid evolution of medical devices poses unique challenges and opportunities in modern healthcare. Health Technology Assessment (HTA) has emerged as a critical mechanism to evaluate not only the ...

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...

The field of early health technology assessment (HTA) and economic evaluation has evolved into a crucial facet of modern healthcare development. By providing preliminary assessments during the ...

Drug value assessments generally fail to account for the complexities of health care systems and thus can misinform price negotiations and lead to overly restrictive access policies. Studies have ...

Unpack NICE's cost-effectiveness thresholds with OHE experts. Explore HTA systems, opportunity cost & emerging evidence in ...